Is Gilead Sciences publicly traded?

Yes, Gilead Sciences is a publicly traded company. It trades on the Nasdaq Stock Exchange under the stock ticker GILD.

Is Gilead Sciences a good company to invest in?

The biopharmaceutical company has an excellent track record of developing innovative drug therapies and increasing shareholder value. It has a strong balance sheet, a good drug pipeline, and won’t face the loss of patent exclusivity until 2036. These are ideal characteristics for a biotechnology company, positioning Gilead to continue growing value for its investors in the future.

What is the ticker for Gilead Sciences?

Gilead Sciences trades under the ticker GILD.

Does Gilead Sciences pay a dividend?

Yes, Gilead Sciences pays a dividend. As of late 2025, Gilead Sciences had paid a dividend every quarter since it initiated the payout in 2015.

How to Buy Gilead Sciences Stock (GILD)

By Matthew DiLallo – Updated Dec 31, 2025 at 1:04 PM EST | Fact-checked by Frank Bass

Key Points

Gilead Sciences offers innovative drugs and boasts a 45,000% return since IPO, highlighting substantial growth.
Investing in Gilead is accessible via brokerage accounts, using simple steps to buy shares.
Strong profits and strategic R&D investments allow Gilead to pay dividends and buy back shares.

Gilead Sciences (GILD +0.27%) is a leading biopharmaceutical company. It has developed innovative medicines to treat HIV, viral hepatitis, COVID-19, cancer, inflammation, and other diseases.

Loading paragraph...

NASDAQ: GILD

Gilead Sciences

Premium Feature

Moneyball Superscore

76/100

Today's Change

(0.27%) $0.40

Current Price

$145.99

Key Data Points

Market Cap

$182B

Day's Range

$142.94 - $146.00

52wk Range

$108.46 - $157.29

Volume

1.8M

Avg Vol

6.8M

Gross Margin

79.66%

Dividend Yield

2.20%

Loading company_card...

The company’s investments in research and development to deliver innovative medicines have paid off for shareholders over the decades. Gilead has delivered a more than 45,000% total return since its initial public offering (IPO) more than 30 years ago, a 21.8% annualized rate.

That robust return makes the pharmaceutical stock a worthwhile consideration for your investment portfolio. Here’s everything you need to know about how to invest in Gilead Sciences stock.

Loading paragraph...

How to buy Gilead Sciences stock

Since it’s a publicly traded company, anyone can buy Gilead Sciences stock. Here’s a step-by-step guide on how to invest money in the pharmaceutical stock:

Open your brokerage account: Log in to your brokerage account where you handle your investments. If you don't have one yet, take a look at our favorite brokers and trading platforms to find the right one for you.
Search for Gilead Sciences: Enter the ticker "GILD" into the search bar to bring up the stock's trading page.
Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
Submit your order: Confirm the details and submit your buy order.
Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.

Loading paragraph...

Should you invest in Gilead Sciences?

Before investing in Gilead Sciences, you need to determine whether the biotech stock is a good fit for your portfolio. Here are some reasons why you might want to buy the stock:

You believe Gilead can continue to develop innovative medicines and grow shareholder value.
You want to invest in companies that pay a growing dividend.
You’re excited by the company’s drug pipeline and believe it has some blockbusters under development.
You want to invest in a pharmaceutical stock that’s not facing a near-term patent cliff (Gildead has no major loss of exclusivity until 2036).
You want to invest in a financially strong biopharma company.

On the other hand, here are some factors that might lead you to reconsider investing in the company:

You’re concerned about potential legislative changes that could hurt the profitability of pharmaceutical companies.
You want to invest in an earlier-stage biotech company with more upside potential.
You already own several other pharmaceutical stocks.
You think rival biotech companies have better drug pipelines and growth prospects.

Loading paragraph...

How to invest in Gilead Sciences through ETFs

Not everyone wants to be an active stock picker and manage a portfolio of individual stocks. An alternative is to consider a passive investment such as an exchange-traded fund (ETF).

Here are a few ETFs to consider for those seeking passive exposure to the biotechnology stock:

VanEck Biotech ETF (NYSEMKT:IBBQ): This fund invests in companies involved in the development and sale of drugs based on genetic analysis and diagnostic equipment. It held more than 26 stocks in late 2025, including Gilead Sciences (second-largest holding at 11.9% of its net assets). The fund charges investors a 0.35% ETF expense ratio.
iShares Biotechnology ETF (NYSEMKT:IBB): The ETF invests in U.S. biotechnology companies. The fund held almost 250 stocks in late 2025, including Gilead Sciences (second-largest holding at 7.2% of its net assets). It had an expense ratio of 0.44%.
Invesco Pharmaceuticals ETF (NYSEMKT:PKP): This ETF invests in pharmaceutical companies. It holds about 30 U.S. pharmaceutical stocks, including Gilead Sciences (the sixth-largest holding, at 4.7% of its assets as of late 2025). The fund has an expense ratio of 0.57%.

Will Gilead Sciences stock split?

Gilead Sciences didn’t have an upcoming stock split as of late 2025. The biotechnology company has completed five stock splits since its initial public offering in 1992:

Loading paragraph...

Data source: Gilead Sciences.
Date	Stock Split Type
February 2001	2-for-1
March 2002	2-for-1
September 2004	2-for-1
June 2007	2-for-1
December 2012	2-for-1

Loading table...

Gilead Sciences’ share price had risen to an all-time high of $124.08 per share (split adjusted) in October 2025. If the share price continues to rise, Gilead might split its stock again to make shares more accessible to a wider range of investors.

Loading paragraph...

The bottom line

Gilead Sciences stands out as a highly profitable pharmaceutical company with a strong balance sheet, no imminent loss of patent exclusivity, and a promising drug pipeline. These strengths put the company in an excellent position to grow shareholder value. For investors seeking stability, innovation, and long-term growth potential in the biopharma sector, Gilead Sciences is a compelling choice.

Loading paragraph...

Investing in Gilead Sciences FAQ

Loading faq...

About the Author

Matt DiLallo has been a contributing Motley Fool stock analyst specializing in the energy, industrials, and real estate sectors since 2012. He also covers dividend-paying stocks, pre-IPO companies, ETFs, and other investing topics. He holds an MBA from Liberty University.

TMFmd19

@MatthewDiLallo

Matt DiLallo has positions in Gilead Sciences. The Motley Fool has positions in and recommends Gilead Sciences. The Motley Fool has a disclosure policy.

How to Buy Gilead Sciences Stock (GILD)

Key Points

NASDAQ: GILD

Key Data Points

How to buy Gilead Sciences stock

Should you invest in Gilead Sciences?

How to invest in Gilead Sciences through ETFs

Will Gilead Sciences stock split?

The bottom line

Related investing topics

Biotech vs. Pharma: What's the Difference?

Pharmaceutical tariffs: Which countries does the U.S. import the most from?

How to Invest in VanEck Biotech ETF (BBH)

Are Stock Splits Good? Here's the Data

Investing in Gilead Sciences FAQ

About the Author

Read Next

Stocks Mentioned

Motley Fool Stock Advisor’s Latest Pick

Premium Investing Services

Biotech vs. Pharma: What's the Difference?

Pharmaceutical tariffs: Which countries does the U.S. import the most from?

How to Invest in VanEck Biotech ETF (BBH)

Are Stock Splits Good? Here's the Data

Investing in Gilead Sciences FAQ

Is Gilead Sciences publicly traded?

Is Gilead Sciences a good company to invest in?

What is the ticker for Gilead Sciences?

Does Gilead Sciences pay a dividend?

How to buy Gilead Sciences stock

Should you invest in Gilead Sciences?

Is Gilead Sciences profitable?

Does Gilead Sciences pay a dividend?

The bottom line

Related investing topics

NASDAQ: GILD

Key Data Points

How to invest in Gilead Sciences through ETFs

Will Gilead Sciences stock split?